Product Information

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $6.0591 per EA under NDC 33342028307. Its NADAC has been published 69 times since Mar 5, 2025.

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB

amlodipine,valsartan and hydrochlorothiazide
$6.0591per EA

Strength

5; 12.5; 160 mg/1; mg/1; mg/1

NDC

33342028307

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207299

On Market Since

1/6/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has been published 69 times since Mar 5, 2025, and over the history we have for it it has declined 11.3%. The table below summarizes its recorded NADAC range and movement.

Current price$6.0591 per EA
All-time high$7.2976 (Jun 11, 2025)
All-time low$6.0591 (Jun 17, 2026)
52-week high$7.2946
52-week low$6.0591
Median price$7.0045
Average price$6.9630
Largest weekly change-7.6% (Jun 17, 2026)
Weeks tracked69
Tracking sinceMar 5, 2025

Price History

1W

0.0%

1M

-7.6%

3M

-13.1%

6M

-10.2%

1Y

-16.6%

3Y

N/A

5Y

N/A

All

-11.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the amlodipine,valsartan and hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $6.0591 per EA (NDC 33342028307), effective Jun 24, 2026.

How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has declined 11.3%. It has been tracked across 69 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has ranged from a low of $6.0591 (Jun 17, 2026) to a high of $7.2976 (Jun 11, 2025), with a median of $7.0045 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB (NDC 33342028307) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.